288 related articles for article (PubMed ID: 15516154)
21. Update on duloxetine for the management of stress urinary incontinence.
Basu M; Duckett JR
Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
[TBL] [Abstract][Full Text] [Related]
22. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
[TBL] [Abstract][Full Text] [Related]
23. The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons.
Mehnert U; Boy S; Widmer-Simitovic S; Reitz A; Schurch B
Int Urogynecol J Pelvic Floor Dysfunct; 2009 Jun; 20(6):659-66. PubMed ID: 19271093
[TBL] [Abstract][Full Text] [Related]
24. [Duloxetine. A new preparation for patients with urinary incontinence].
Walter S
Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
[TBL] [Abstract][Full Text] [Related]
25. Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial.
Lin AT; Sun MJ; Tai HL; Chuang YC; Huang ST; Wang N; Zhao YD; Beyrer J; Wulster-Radcliffe M; Levine L; Chang C; Viktrup L
BMC Urol; 2008 Jan; 8():2. PubMed ID: 18221532
[TBL] [Abstract][Full Text] [Related]
26. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence.
Cardozo L; Lange R; Voss S; Beardsworth A; Manning M; Viktrup L; Zhao YD
Curr Med Res Opin; 2010 Feb; 26(2):253-61. PubMed ID: 19929591
[TBL] [Abstract][Full Text] [Related]
27. What do we know about duloxetine's mode of action? Evidence from animals to humans.
Schuessler B
BJOG; 2006 May; 113 Suppl 1():5-9. PubMed ID: 16529563
[TBL] [Abstract][Full Text] [Related]
28. Duloxetine: a dual reuptake inhibitor.
Dugan SE; Fuller MA
Ann Pharmacother; 2004 Dec; 38(12):2078-85. PubMed ID: 15522980
[TBL] [Abstract][Full Text] [Related]
29. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.
Thor KB
Urology; 2003 Oct; 62(4 Suppl 1):3-9. PubMed ID: 14550831
[TBL] [Abstract][Full Text] [Related]
30. Impact of duloxetine on quality of life for women with symptoms of urinary incontinence.
Kinchen KS; Obenchain R; Swindle R
Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(5):337-44. PubMed ID: 15662490
[TBL] [Abstract][Full Text] [Related]
31. Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats.
Miyazato M; Kaiho Y; Kamo I; Chancellor MB; Sugaya K; de Groat WC; Yoshimura N
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F264-71. PubMed ID: 18480175
[TBL] [Abstract][Full Text] [Related]
32. Duloxetine pharmacology: profile of a dual monoamine modulator.
Karpa KD; Cavanaugh JE; Lakoski JM
CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192
[TBL] [Abstract][Full Text] [Related]
33. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
Rabasseda X
Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
[TBL] [Abstract][Full Text] [Related]
34. A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence.
Ghoniem GM; Van Leeuwen JS; Elser DM; Freeman RM; Zhao YD; Yalcin I; Bump RC;
J Urol; 2005 May; 173(5):1647-53. PubMed ID: 15821528
[TBL] [Abstract][Full Text] [Related]
35. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.
Bent AE; Gousse AE; Hendrix SL; Klutke CG; Monga AK; Yuen CK; Muram D; Yalcin I; Bump RC
Neurourol Urodyn; 2008; 27(3):212-21. PubMed ID: 17580357
[TBL] [Abstract][Full Text] [Related]
36. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
Häuser W; Urrútia G; Tort S; Uçeyler N; Walitt B
Cochrane Database Syst Rev; 2013 Jan; (1):CD010292. PubMed ID: 23440848
[TBL] [Abstract][Full Text] [Related]
37. [Duloxetine in the treatment of urinary incontinence in women].
Lello S; Paoletti AM; Guardianelli F; Floris S; Melis M; Melis GB
Minerva Ginecol; 2004 Aug; 56(4):349-52. PubMed ID: 15377983
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
Schatzberg AF
J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
[TBL] [Abstract][Full Text] [Related]
39. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis.
Li J; Yang L; Pu C; Tang Y; Yun H; Han P
Int Urol Nephrol; 2013 Jun; 45(3):679-86. PubMed ID: 23504618
[TBL] [Abstract][Full Text] [Related]
40. Duloxetine: a review of its pharmacology and use in chronic pain management.
Bellingham GA; Peng PW
Reg Anesth Pain Med; 2010; 35(3):294-303. PubMed ID: 20921842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
